As a global CDMO leader, Asymchem (002821.SZ/6821.HK) offers end-to-end pharmaceutical solutions, excelling in small molecules, macromolecules, biologics, drug products, synthetic biology, and more. With over 9,000 professionals and multiple facilities worldwide, we ensure cGMP compliance, cost efficiency, and client-centric services, empowering partners to accelerate drug development and commercialization.